BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 11, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 25, 2009
View Archived Issues
Recombinant T-cell receptor ligand RTL-551 reduces stroke lesion size in vivo
Read More
Unique androgen receptor antagonists identified at Duke University Medical Center
Read More
Phase I/II studies show low systemic absorption of dapivirine vaginal gel
Read More
Novartis has disclosed novel ALK inhibitors for obstructive airways diseases
Read More
TRPA1 antagonists claimed as analgesics by Abbott
Read More
Exelixis reports creation of protein kinase inhibitors as anticancer agents
Read More
Monoamine oxidase inhibitors developed as antibacterials at Ferrer
Read More
GSK describes novel mGlu5 receptor antagonists for substance abuse
Read More
Novel hypoxia-inducible factor inhibitors reported by FibroGen
Read More
Novo Nordisk presents results for second quarter 2009
Read More
New Levitra formulation submitted for registration in E.U.
Read More
Resolvyx presents data from phase II trial of RX-10045 in dry eye syndrome
Read More
Intercept Blood System for platelets receives Swiss approval
Read More
Liverpool School of Tropical Medicine leads antimalarial drug research project
Read More
Bavarian Nordic enters negotiations with U.S. authorities for Imvamune
Read More
MF-482 developed as a second-generation EP4 antagonist for treating inflammatory pain
Read More
Takeda describes preclinical profile of GnRH antagonist TAK-385
Read More
Abbott presents PAMs that target the alpha7 nicotinic acetylcholine receptor
Read More
Seattle Genetics completes enrollment in pivitol brentuximab vedotin trial
Read More
Three phase II studies of H1N1 influenza vaccine CSL-425 planned or under way
Read More
Santaris forms strategic alliance with Shire to develop RNA-based medicines
Read More
Valeant reports preliminary results of phase IIa retigabine study in PHN
Read More
Xyzal approved for use in young children
Read More
Ligand to acquire Neurogen
Read More
BioCancell's ovarian cancer drug granted orphan drug status in U.S.
Read More
Gloucester to meet with FDA Advisory Committee to discuss romidepsin NDA
Read More